-
Je něco špatně v tomto záznamu ?
Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes
K. Urbańczyk, S. Guntschnig, V. Antoniadis, S. Falamic, T. Kovacevic, M. Kurczewska-Michalak, B. Miljković, A. Olearova, I. Sviestina, A. Szucs, K. Tachkov, Z. Tiszai, D. Volmer, A. Wiela-Hojeńska, D. Fialova, J. Vlcek, M. Stuhec, A. Hogg, M....
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
- Publikační typ
- časopisecké články MeSH
Clinical pharmacy as an area of practice, education and research started developing around the 1960s when pharmacists across the globe gradually identified the need to focus more on ensuring the appropriate use of medicines to improve patient outcomes rather than being engaged in manufacturing and supply. Since that time numerous studies have shown the positive impact of clinical pharmacy services (CPS). The need for wider adoption of CPS worldwide becomes urgent, as the global population ages, and the prevalence of polypharmacy as well as shortage of healthcare professionals is rising. At the same time, there is great pressure to provide both high-quality and cost-effective health services. All these challenges urgently require the adoption of a new paradigm of healthcare system architecture. One of the most appropriate answers to these challenges is to increase the utilization of the potential of highly educated and skilled professionals widely available in these countries, i.e., pharmacists, who are well positioned to prevent and manage drug-related problems together with ensuring safe and effective use of medications with further care relating to medication adherence. Unfortunately, CPS are still underdeveloped and underutilized in some parts of Europe, namely, in most of the Central and Eastern European (CEE) countries. This paper reviews current situation of CPS development in CEE countries and the prospects for the future of CPS in that region.
Children's Clinical University Hospital Riga Latvia
College of Pharmacy QU Health Qatar University Doha Qatar
Department of Clinical Pharmacology Wroclaw Medical University Wroclaw Poland
Department of Clinical Pharmacy Ormoz Psychiatric Hospital Ormoz Slovenia
Department of Family Medicine Medical University of Lodz Lodz Poland
Department of Hospital Pharmacy Bajcsy Zsilinszky Hospital Budapest Hungary
Department of Pharmacology Faculty of Medicine Maribor University of Maribor Maribor Slovenia
European Directorate for the Quality of Medicines and Healthcare Council of Europe Strasbourg France
European Society of Clinical Pharmacy Leiden Netherlands
Faculty of Medicine University of Latvia Riga Latvia
Independent Expert Thessaloniki Greece
Institute of Pharmacy Faculty of Medicine University of Tartu Tartu Estonia
Medicines Optimisation Innovation Centre Antrim Hospital Antrim United Kingdom
Pharmacy Department National Institute of Oncology Budapest Hungary
Regional Specialist Hospital in Wroclaw Wroclaw Poland
School of Pharmacy and Pharmaceutical Sciences Ulster University Coleraine Northern Ireland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23015536
- 003
- CZ-PrNML
- 005
- 20231020093455.0
- 007
- ta
- 008
- 231010s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fphar.2023.1244151 $2 doi
- 035 __
- $a (PubMed)37601045
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Urbańczyk, Kamila $u Department of Clinical Pharmacology, Wroclaw Medical University, Wroclaw, Poland $u Regional Specialist Hospital in Wroclaw, Wroclaw, Poland
- 245 10
- $a Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes / $c K. Urbańczyk, S. Guntschnig, V. Antoniadis, S. Falamic, T. Kovacevic, M. Kurczewska-Michalak, B. Miljković, A. Olearova, I. Sviestina, A. Szucs, K. Tachkov, Z. Tiszai, D. Volmer, A. Wiela-Hojeńska, D. Fialova, J. Vlcek, M. Stuhec, A. Hogg, M. Scott, D. Stewart, A. Mair, S. Ravera, FX. Lery, P. Kardas
- 520 9_
- $a Clinical pharmacy as an area of practice, education and research started developing around the 1960s when pharmacists across the globe gradually identified the need to focus more on ensuring the appropriate use of medicines to improve patient outcomes rather than being engaged in manufacturing and supply. Since that time numerous studies have shown the positive impact of clinical pharmacy services (CPS). The need for wider adoption of CPS worldwide becomes urgent, as the global population ages, and the prevalence of polypharmacy as well as shortage of healthcare professionals is rising. At the same time, there is great pressure to provide both high-quality and cost-effective health services. All these challenges urgently require the adoption of a new paradigm of healthcare system architecture. One of the most appropriate answers to these challenges is to increase the utilization of the potential of highly educated and skilled professionals widely available in these countries, i.e., pharmacists, who are well positioned to prevent and manage drug-related problems together with ensuring safe and effective use of medications with further care relating to medication adherence. Unfortunately, CPS are still underdeveloped and underutilized in some parts of Europe, namely, in most of the Central and Eastern European (CEE) countries. This paper reviews current situation of CPS development in CEE countries and the prospects for the future of CPS in that region.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Guntschnig, Sonja $u Tauernklinikum Zell am See, Zell am See, Austria $u School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, Northern Ireland
- 700 1_
- $a Antoniadis, Vasilis $u Independent Expert, Thessaloniki, Greece
- 700 1_
- $a Falamic, Slaven $u Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
- 700 1_
- $a Kovacevic, Tijana $u Pharmacy Department, University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina $u Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
- 700 1_
- $a Kurczewska-Michalak, Marta $u Department of Family Medicine, Medical University of Lodz, Lodz, Poland
- 700 1_
- $a Miljković, Branislava $u Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
- 700 1_
- $a Olearova, Anna $u Department of Clinical Pharmacology, University Hospital Bratislava-Hospital Ruzinov, Bratislava, Slovakia
- 700 1_
- $a Sviestina, Inese $u Faculty of Medicine, University of Latvia, Riga, Latvia $u Children's Clinical University Hospital, Riga, Latvia
- 700 1_
- $a Szucs, Attila $u Pharmacy Department, National Institute of Oncology, Budapest, Hungary
- 700 1_
- $a Tachkov, Konstantin $u Department of Organization and Economy of Pharmacy, Faculty of Pharmacy, Medical University-Sofia, Sofia, Bulgaria
- 700 1_
- $a Tiszai, Zita $u Department of Hospital Pharmacy, Bajcsy-Zsilinszky Hospital, Budapest, Hungary
- 700 1_
- $a Volmer, Daisy $u Institute of Pharmacy, Faculty of Medicine, University of Tartu, Tartu, Estonia
- 700 1_
- $a Wiela-Hojeńska, Anna $u Department of Clinical Pharmacology, Wroclaw Medical University, Wroclaw, Poland
- 700 1_
- $a Fialova, Daniela $u Department of Clinical and Social Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czechia $u Department of Geriatrics and Gerontology, First Faculty of Medicine in Prague, Charles University, Prague, Czechia
- 700 1_
- $a Vlcek, Jiri $u Department of Clinical and Social Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czechia $u Clinical Pharmacy Department, Hospital Pharmacy, Teaching Hospital Hradec Kralove, Hradec Králové, Czechia
- 700 1_
- $a Stuhec, Matej $u Department of Pharmacology, Faculty of Medicine Maribor, University of Maribor, Maribor, Slovenia $u Department of Clinical Pharmacy, Ormoz Psychiatric Hospital, Ormoz, Slovenia
- 700 1_
- $a Hogg, Anita $u Medicines Optimisation Innovation Centre, Antrim Hospital, Antrim, United Kingdom
- 700 1_
- $a Scott, Michael $u Medicines Optimisation Innovation Centre, Antrim Hospital, Antrim, United Kingdom
- 700 1_
- $a Stewart, Derek $u College of Pharmacy, QU Health, Qatar University, Doha, Qatar $u European Society of Clinical Pharmacy, Leiden, Netherlands
- 700 1_
- $a Mair, Alpana $u Effective Prescribing and Therapeutics, Health and Social Care Directorate, Scottish Government, Edinburgh, United Kingdom
- 700 1_
- $a Ravera, Silvia $u European Directorate for the Quality of Medicines & Healthcare, Council of Europe, Strasbourg, France
- 700 1_
- $a Lery, François-Xavier $u European Directorate for the Quality of Medicines & Healthcare, Council of Europe, Strasbourg, France
- 700 1_
- $a Kardas, Przemysław $u Department of Family Medicine, Medical University of Lodz, Lodz, Poland
- 773 0_
- $w MED00174597 $t Frontiers in pharmacology $x 1663-9812 $g Roč. 14, č. - (2023), s. 1244151
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37601045 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231010 $b ABA008
- 991 __
- $a 20231020093448 $b ABA008
- 999 __
- $a ok $b bmc $g 1997174 $s 1201898
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 14 $c - $d 1244151 $e 20230802 $i 1663-9812 $m Frontiers in pharmacology $n Front Pharmacol $x MED00174597
- LZP __
- $a Pubmed-20231010
